You are here

Article info

Article menu
Download PDFPDF
Clinical science
Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusion

Authors

  1. Correspondence to Dr Fumiki Okamoto, Department of Ophthalmology, University of Tsukuba Faculty of Medicine, Tsukuba, Ibaraki 305-8577, Japan; fumiki-o{at}md.tsukuba.ac.jp
View Full Text

Citation

Murakami T, Okamoto F, Sugiura Y, et al
Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusion
British Journal of Ophthalmology 2023;107:254-260.

Publication history

  • Received June 11, 2021
  • Accepted August 17, 2021
  • First published August 27, 2021.
Online issue publication 
January 20, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.